IRIS - Res&Arch Institutional Research Information System - Research & Archive

VEDOVATI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.544
EU - Europa 1.180
AS - Asia 474
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.202
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.534
IE - Irlanda 371
IT - Italia 330
SG - Singapore 142
HK - Hong Kong 120
UA - Ucraina 113
SE - Svezia 97
VN - Vietnam 87
CN - Cina 82
FI - Finlandia 71
RU - Federazione Russa 57
DE - Germania 43
FR - Francia 33
GB - Regno Unito 21
TR - Turchia 18
BE - Belgio 10
KR - Corea 9
CA - Canada 7
CH - Svizzera 7
UZ - Uzbekistan 6
AT - Austria 5
ES - Italia 4
GR - Grecia 4
LB - Libano 4
NL - Olanda 4
PL - Polonia 4
JP - Giappone 3
MX - Messico 3
BR - Brasile 2
CZ - Repubblica Ceca 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
IN - India 1
OM - Oman 1
PT - Portogallo 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.202
Salva come PNG Salva come JPEG
Città #
Dublin 371
Chandler 325
San Mateo 174
Altamura 120
Hong Kong 120
Perugia 106
Ann Arbor 90
Medford 89
Princeton 89
Singapore 89
Lawrence 88
Dong Ket 86
Jacksonville 57
Wilmington 48
Andover 46
Beijing 39
Redmond 36
Des Moines 30
Los Angeles 19
Redwood City 19
Saint Petersburg 19
Izmir 15
Norwalk 14
San Paolo di Civitate 14
Woodbridge 14
Amelia 13
Helsinki 13
Rome 11
Brussels 10
Seoul 9
New York 8
Lappeenranta 6
Moscow 6
Shanghai 6
Ashburn 5
Falls Church 4
Lausanne 4
Ottawa 4
Toledo 4
Boardman 3
Clifton 3
Den Haag 3
Milan 3
Nanning 3
Nuremberg 3
Tokyo 3
Bad Muenstereifel 2
Córdoba 2
Frankfurt Am Main 2
Frankfurt am Main 2
Garbagnate Milanese 2
Gunzenhausen 2
Houston 2
Loma Linda 2
Madrid 2
Menlo Park 2
Piediluco 2
Pisa 2
Rostock 2
Salerno 2
Simi Valley 2
Toronto 2
Aberdeen 1
Acquasparta 1
Albignasego 1
Amsterdam 1
Angra dos Reis 1
Athens 1
Auburn Hills 1
Augusta 1
Bologna 1
Buggiano 1
Chennai 1
Clearwater 1
Feltham 1
Fiesole 1
Fremont 1
Hanover 1
Ho Chi Minh City 1
Honolulu 1
Istanbul 1
Kiev 1
Lake Country 1
Lisbon 1
London 1
Marseille 1
Massarosa 1
Pavia 1
Pieve 1
Porcia 1
Reggio Calabria 1
Salalah 1
San Diego 1
San Francisco 1
Seattle 1
Sofia 1
Taipei 1
Temple City 1
Timisoara 1
Vienna 1
Totale 2.311
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 94
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 91
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 82
Thrombophilia and cerebral vein thrombosis 75
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 69
Aspirin for preventing the recurrence of venous thromboembolism. 67
Antecolic or Retrocolic Alimentary Limb in Laparoscopic Roux-en-Y Gastric Bypass? A Meta-Analysis 61
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 60
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 56
Combined oral anticoagulants and antiplatelets: benefits and risks. 55
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 55
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 54
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 52
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 50
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 50
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 49
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 49
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 48
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 47
Reply 47
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 46
[2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism: what's new?] 46
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 45
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 44
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 44
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 44
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 43
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 43
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 43
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 42
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation 42
Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. 40
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 40
Carotid plaque detection improves the predictve value of CHA 2 DS 2 -VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 40
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 39
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 39
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 37
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 37
Patients with acute pulmonary embolism at intermediate risk for death: Can we further stratify? 37
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 36
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 36
Intra-abdominal drainage after pancreatic resection: Is it really necessary? A meta-analysis of short-term outcomes 36
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 35
Multidetectorcomputed tomography for acute pulmonary embolism: diagnosis and riskstratification in a single test. 34
Predictors of new onset atrial fibrillation after myocardial infarction 34
Beyond the guidelines: Novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism 34
MDCT-detected embolic burden and clinical outcome in patients with acute pulmonary embolism 34
Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. 33
Old and new oral anticoagulants forvenous thromboembolism and atrial fibrillation: A review of the literature. 32
To drain or not to drain elective uncomplicated laparoscopic cholecystectomy? A systematic review and meta-analysis 32
Thrombotic risk after a major bleeding during anticoagulation: A clinical case 32
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 32
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study 32
Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. 31
To drain or not to drain extraperitoneal colorectal anastomosis? A systematic review and meta-analysis. 31
A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer 31
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants 31
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 31
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 31
Right ventricle dysfunction in patients with pulmonary embolism. 30
Prognostic value of troponins in acutepulmonary embolism: a meta-analysis. 30
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 30
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study 29
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 28
One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study 27
Prognostic value of the CHA2DS2Vasc score in patients experiencing a myocardial infarction 27
Accuracy of Physicians in Differentiating Type 1 and Type 2 Myocardial Infarction Based on Clinical Information 27
Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight 26
Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: A case report 26
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis 25
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management 25
Efficacy and safety of direct oral anticoagulants after pulmonary embolism: A meta-analysis 24
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 24
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 23
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 23
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. 22
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 22
Novel oral anticoagulants in patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 22
Novel oral anticoagulants for patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 22
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 21
Efficacy and safety of novel oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis 20
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 18
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE 16
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 14
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 13
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study 12
Shock and diffuse ST-elevation in a patient with coronavirus disease-2019 disease 12
Patients with Atrial Fibrillation receiving NOACs: The boundary between appropriate and inappropriate dose 12
Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study 11
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 11
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 10
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis 9
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism 9
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 8
MAJOR ACUTE CARDIOVASCULAR EVENTS AFTER VENOUS THROMBOEMBOLISM: A META-ANALYSIS OF RANDOMIZED TRIALS 7
[A new anticoagulant strategy: the factor XI inhibitors] 7
Time to Use Direct Oral Anticoagulants to Prevent Recurrences and Major Acute Cardiovascular Events After VTE? 6
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 6
[Anticoagulation therapy during pulmonary embolism follow-up in clinical practice] 6
A new strategy for anticoagulation: The factor XI inhibitors 6
Totale 3.406
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 8 21 25 4 18 1 16 9 25 42 11 5
2020/2021454 3 21 12 17 178 28 27 14 28 13 24 89
2021/2022687 7 125 8 20 32 4 8 204 24 59 89 107
2022/20231.264 93 291 18 71 76 121 0 45 488 5 33 23
2023/2024491 26 54 29 9 6 1 107 3 37 35 103 81
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 3.430